Mark Cuban Cost Plus Drug Company has announced two significant partnerships aimed at expanding access to affordable prescription medications through innovative healthcare delivery models. The collaborations with Healthee and 9amHealth represent strategic moves to integrate transparent drug pricing into comprehensive healthcare solutions for employers and employees.
Partnership with Healthee Targets Employee Benefits
The partnership between Cost Plus Drugs and Healthee, announced in April 2025, integrates the pharmaceutical company's direct-to-consumer model into Healthee's AI-powered benefits platform. This collaboration addresses the rising burden of prescription drug costs for both employees and employers by providing transparent, low-cost access to medications.
"The rising cost of prescription drugs is a major burden for both employees and employers," said Guy Benjamin, CEO & Co-founder of Healthee. "By teaming up with Mark Cuban Cost Plus Drug Company, we are taking another step toward making healthcare more transparent, affordable, and accessible."
Through this integration, Healthee users gain seamless access to Cost Plus Drug's prescription pricing and purchasing options, enabling cost-conscious healthcare decisions. Employers benefit from lower claims costs and improved medication adherence among their workforce.
9amHealth Collaboration Focuses on Obesity Care
In June 2025, Cost Plus Drugs announced a collaboration with 9amHealth to expand access to affordable obesity care through employer benefit plans. This partnership combines Cost Plus Drugs' low-cost oral medications with 9amHealth's clinically validated prescribing protocols and expert-led cardiometabolic care.
The collaboration addresses the skyrocketing demand for weight-loss medications while providing employers with a cost-efficient solution for weight management and chronic co-conditions including diabetes, high cholesterol, and hypertension.
"We are thrilled to collaborate with 9amHealth in our mission to make prescription drugs more affordable for consumers," said Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company. "With clinical leaders in obesity like 9amHealth, we are dedicated to providing affordable and accessible healthcare solutions for patients with cardiometabolic conditions."
Comprehensive Care Model
The 9amHealth partnership offers employers a turnkey solution that includes virtual medical care from obesity medicine physicians and endocrinologists, access to first-generation obesity medications at transparent prices, coverage for branded obesity GLP-1 medications at fixed monthly costs, at-home lab testing, prescription delivery, and 24/7 clinical support.
"Our collaboration with Mark Cuban Cost Plus Drugs gives employers a way to provide expert medical management of obesity, without the massive price tag," said Paul Geevarghese, COO and Co-Founder of 9amHealth. "We're connecting members to real, human care: specialists in obesity and diabetes, clinical pharmacists, and ongoing nutritional support with registered dietitians."
Transparent Pricing Model
Cost Plus Drugs operates as a public-benefit corporation with a mission to fundamentally change pharmaceutical industry operations. The company's transparent pricing model eliminates middlemen and charges a standard markup on every drug sold. Since launching its online pharmacy in January 2022, the platform now carries over 2,300 prescription products delivered by mail to thousands of customers daily.
The company also provides Cost Plus Drugs pricing through the Team Cuban Card at participating retail pharmacies and works with health plans, managed-care organizations, pharmacy benefits managers, and self-insured employers to bring savings to employer-sponsored benefit plans nationwide.
These partnerships represent Cost Plus Drugs' continued expansion into comprehensive healthcare solutions, leveraging its transparent pricing foundation to address broader healthcare access challenges in the employer benefits market.
